LGC Science has tested and cleared PerfectAmino for the wide range of substances banned by the World Anti-Doping Agency.
Photo © iStockphoto.com/Aksonov
PerfectAmino, an amino-acid supplement designed for the sports-nutrition market from BodyHealth (Clearwater, FL), has now been tested and successfully cleared by LGC Science (Lexington, KY) for the wide range of substances banned by the World Anti-Doping Agency (WADA). With that confirmation that PerfectAmino is free of banned substances, including steroids, stimulants, diuretics, masking agents, and more, BodyHealth says the product is more appropriate for elite athletes than ever.
“PerfectAmino’s clean bill of health not only speaks to the supplement’s purity and safety, but also gives strong assurance to elite and professional athletes that our amino-acid supplement has been cleared for use before, during, and after competitive and sanctioned events,” said David Minkoff, MD, founder of BodyHealth, in the press announcement.
LGC’s testing method identifies 147 core illicit substances that have been identified on the WADA Prohibited List or by other professional sports organizations, including the NFL, MLB, NBA, and more. Its testing capability is able to detect banned substance contaminants at levels of just 10 parts per billion (10 ng/g) or less.
PerfectAmino contains all eight of the essential amino acids in ratios designed to “support and maintain [the body’s] muscular, skeletal, enzymatic, and hormonal systems,” according to BodyHealth.
Read more:
Sustained-Release Beta-Alanine Allows for Higher Dosing: SupplySide West Report
2016 Sports Nutrition Ingredient Trends
Is Egg Protein Poised for a Sports-Nutrition Comeback?
Michael Crane
Associate Editor
Nutritional Outlook Magazine
michael.crane@ubm.com
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.